Logo

American Heart Association

  10
  0


Final ID: MDP1287

Development of a Sitosterolemia Risk Prediction Scale (SRPS): A Screening Tool

Abstract Body (Do not enter title and authors here): Introduction: Sitosterolemia, a hereditary disorder marked by elevated plant sterol levels, presents diagnostic challenges due to its similarity to other lipid disorders. The development of the Sitosterolemia Risk Prediction Scale (SRPS) aims to address this by synthesising genetic, clinical, and dietary data into a coherent risk assessment model.
Research Question: We propose that a structured risk scale, integrating diverse factors known to affect sitosterolemia, can significantly improve the accuracy of predicting the disorder. The SRPS is hypothesised to facilitate early detection and inform targeted interventions.
Aim: The primary aim is to conceptualise and outline the SRPS, which categorises individuals into risk categories based on a point system reflecting genetic predispositions, clinical symptoms, dietary habits, and response to treatments. This scale seeks to enhance the clinical identification of sitosterolemia, promoting timely and personalised management strategies.
Methods: A detailed table was generated to present the SRPS, categorising risk factors into genetic, clinical, dietary, and response to treatment. This innovative method allowed for the efficient synthesis and visualisation of complex data.
Results: The SRPS table methodically organizes risk factors into low (0-2 points), moderate (3-5 points), and high (6+ points) categories. This stratification guides further diagnostic actions, ranging from exploring alternative causes of hyperlipidemia to necessitating comprehensive genetic and lipid analyses.
Conclusion:The SRPS represents an innovative framework for assessing sitosterolemia risk, highlighting the potential benefits of integrating genetic, clinical, and dietary information. It further underscores the importance of a multifactorial approach in the early detection and management of sitosterolemia.
  • Tawde, Poonam  ( Avalon University School Of Medicine , Mesa , Arizona , United States )
  • Mohammad, Salim  ( Chandler Regional Medical Center , Chandler , Arizona , United States )
  • Author Disclosures:
    Poonam Tawde: DO NOT have relevant financial relationships | Salim Mohammad: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

New Mechanisms in Atherosclerosis

Monday, 11/18/2024 , 12:50PM - 02:15PM

Moderated Digital Poster Session

More abstracts on this topic:
A Pharmacovigilance Study of Bempedoic Acid: Balancing Risks and Benefits

Khadka Sulochana, Timilsina Bibek, Matai Pallavi, Sharma Seema, Rajak Kripa, Calderon Barahona Gabriela, Oli Seema

A Randomized Placebo-Controlled Trial of Pitavastatin Calcium to Treat Combined Dyslipidemia of Obesity in Adolescents – The Pediatric Heart Network Dyslipidemia of Obesity Intervention in Teens (DO IT!) Trial

De Ferranti Sarah, Cartoski Mark, Brothers Julie, San Giovanni Christine, Zachariah Justin, Pena Sandra, Mahle William, Peterson Amy, Magge Sheela, Raghuveer Geetha, Sharma Binu, Arslanian, Md Silva, Kazlova Valiantsina, Sponseller Craig, Freemon Dandrea, Stylianou Mario, Mccrindle Brian, Mietus-snyder Michele, Urbina Elaine, Ware Adam, Teng Jessica, Trachtenberg Felicia, Russell Mark, Shah Amy

You have to be authorized to contact abstract author. Please, Login
Not Available